vimarsana.com

Latest Breaking News On - Science summit - Page 7 : vimarsana.com

Reflex Molecular Testing May Enhance Targeted Therapy Benefit in Early-Stage Lung Cancer

Jobelle Baldonado, MD, highlights the emergence of targeted therapies and the need for reflex-ordered molecular testing in early-stage lung cancer.

Florida
United-states
Tampa
Theresa-boyle
Jobelle-baldonado
Andreas-saltos
George-simon
Moffitt-cancer-center
Department-of-thoracic-oncology
Onclive-state
Science-summit
Thoracic-oncology

Value Research Center (VRC) At SSUNGA78: 'How Purpose, Value, And Impact Will Drive A Sustainable Post-SDG Future'

Value Research Center (VRC) At SSUNGA78: 'How Purpose, Value, And Impact Will Drive A Sustainable Post-SDG Future'
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Kyoto
Japan
Cambridge
Cambridgeshire
United-kingdom
Osaka
Okinawa
Toshiya-hoshino
Philip-sugai
Haruko-satoh

Updates to MDS Classification Complicate Yet Better Inform Treatment Navigation in MDS

Mikkael A. Sekeres, MD, MS, discusses the influence of therapeutic developments and conflicting classification systems on the management of MDS.

Florida
United-states
University-of-miami
Namrata-chandhok
Mikkaela-sekeres
World-health-organization
Division-of-hematology
International-prognostic-scoring-system
Sylvester-comprehensive-cancer-center
University-of-miami-health-system
International-consensus-classification
Onclive-state

Recent Approvals Across Hematologic Malignancies Usher in a New Era

Mikkael A. Sekeres, MD, MS, highlights recent approvals and emerging therapeutics in hematologic malignancies discussed by his colleagues.

University-of-miami
Florida
United-states
Terrencej-bradley
Mikkaela-sekeres
Alvaro-alencar
Juan-alderuccio
International-prognostic-index
University-of-miami-health-system
Sylvester-comprehensive-cancer-center
Division-of-hematology
Onclive-state

McAndrews Expands on the Evolving Treatment Armamentarium in HER2+ Breast Cancer

Nicholas P. McAndrew, MD, MSCE, discusses how updated clinical trial findings are shifting the treatment paradigm in HER2-positive metastatic breast cancer.

San-antonio
Texas
United-states
California
Los-angeles
Nicholasp-mcandrew
David-geffen-school-of-medicine
University-of-california
Antonio-breast-cancer-symposium
Science-summit
Geffen-school

vimarsana © 2020. All Rights Reserved.